NTRB vs. EYEN, LPCN, LFWD, MLSS, RBOT, CLGN, COCH, RVP, ACHL, and INKT
Should you be buying Nutriband stock or one of its competitors? The main competitors of Nutriband include Eyenovia (EYEN), Lipocine (LPCN), ReWalk Robotics (LFWD), Milestone Scientific (MLSS), Vicarious Surgical (RBOT), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), Retractable Technologies (RVP), Achilles Therapeutics (ACHL), and MiNK Therapeutics (INKT). These companies are all part of the "medical" sector.
Eyenovia (NASDAQ:EYEN) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, community ranking, media sentiment, earnings, dividends and risk.
Eyenovia has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. Comparatively, Nutriband has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500.
Eyenovia currently has a consensus price target of $10.00, suggesting a potential upside of 1,491.85%. Given Nutriband's higher possible upside, equities research analysts clearly believe Eyenovia is more favorable than Nutriband.
Nutriband has higher revenue and earnings than Eyenovia. Nutriband is trading at a lower price-to-earnings ratio than Eyenovia, indicating that it is currently the more affordable of the two stocks.
25.8% of Eyenovia shares are owned by institutional investors. Comparatively, 19.7% of Nutriband shares are owned by institutional investors. 7.8% of Eyenovia shares are owned by company insiders. Comparatively, 43.2% of Nutriband shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Eyenovia received 166 more outperform votes than Nutriband when rated by MarketBeat users. Likewise, 65.00% of users gave Eyenovia an outperform vote while only 37.50% of users gave Nutriband an outperform vote.
Eyenovia has a net margin of 0.00% compared to Eyenovia's net margin of -252.90%. Eyenovia's return on equity of -73.13% beat Nutriband's return on equity.
In the previous week, Nutriband had 4 more articles in the media than Eyenovia. MarketBeat recorded 6 mentions for Nutriband and 2 mentions for Eyenovia. Nutriband's average media sentiment score of 0.00 beat Eyenovia's score of -0.38 indicating that Eyenovia is being referred to more favorably in the media.
Summary
Eyenovia beats Nutriband on 9 of the 15 factors compared between the two stocks.
Get Nutriband News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nutriband Competitors List
Related Companies and Tools
